SI1501505T1 - Uporaba (3-(2-etilfenil)-5-metoksifenil)-1H-1,2,4-triazola za zdravljenje avtoimunskih bolezni - Google Patents

Uporaba (3-(2-etilfenil)-5-metoksifenil)-1H-1,2,4-triazola za zdravljenje avtoimunskih bolezni

Info

Publication number
SI1501505T1
SI1501505T1 SI200330176T SI200330176T SI1501505T1 SI 1501505 T1 SI1501505 T1 SI 1501505T1 SI 200330176 T SI200330176 T SI 200330176T SI 200330176 T SI200330176 T SI 200330176T SI 1501505 T1 SI1501505 T1 SI 1501505T1
Authority
SI
Slovenia
Prior art keywords
ethylphenyl
triazole
methoxyphenyl
treatment
autoimmune diseases
Prior art date
Application number
SI200330176T
Other languages
English (en)
Inventor
L Battistini
G Borsellino
Santis R De
P Carminati
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/137,699 external-priority patent/US6797722B2/en
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SI1501505T1 publication Critical patent/SI1501505T1/sl

Links

SI200330176T 2002-05-03 2003-04-15 Uporaba (3-(2-etilfenil)-5-metoksifenil)-1H-1,2,4-triazola za zdravljenje avtoimunskih bolezni SI1501505T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/137,699 US6797722B2 (en) 2002-05-03 2002-05-03 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
PCT/IT2003/000237 WO2003092681A1 (en) 2002-05-03 2003-04-15 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases
EP03720879A EP1501505B1 (en) 2002-05-03 2003-04-15 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -triazole for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
SI1501505T1 true SI1501505T1 (sl) 2006-04-30

Family

ID=36808308

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330176T SI1501505T1 (sl) 2002-05-03 2003-04-15 Uporaba (3-(2-etilfenil)-5-metoksifenil)-1H-1,2,4-triazola za zdravljenje avtoimunskih bolezni

Country Status (1)

Country Link
SI (1) SI1501505T1 (sl)

Similar Documents

Publication Publication Date Title
AP1997A (en) 3-(3,5-dioxo-4,5-dihydro-3H-(1,2,4)triazin-2-YL)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
PL1656346T3 (pl) 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
PT1471065E (pt) Novos compostos de 1,2,4-triazole
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
SI1530466T1 (sl) Uporaba nintedaniba za zdravljenje pljučne fibroze
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
GB0213869D0 (en) The treatment of pain
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
AU2002254947A1 (en) Kappa opiate agonists for the treatment of bladder diseases
SI1501505T1 (sl) Uporaba (3-(2-etilfenil)-5-metoksifenil)-1H-1,2,4-triazola za zdravljenje avtoimunskih bolezni
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
IL166303A0 (en) Crystal modification of 2-Ä2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxy-propylÜ-2,4-dihydro-3h-1,2,4-triazole-3-thions
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
GB0201025D0 (en) The treatment of degenerative diseases
GB0223650D0 (en) Psoriasis treatment
AU2002247836A1 (en) Mycobacterrial estracts for treating autoimmune diseases
AU2003277979A8 (en) Regulation of gene expression using intron 1 of the ly-6 gene superfamily
GB0120783D0 (en) The treatment of lupus nephritis